Literature DB >> 28063739

Development of Left Atrial Thrombus After Coadministration of Dabigatran Etexilate and Phenytoin.

Nicole Hager1, Jennifer Bolt2, Lori Albers2, Wladyslaw Wojcik3, Patrick Duffy4, William Semchuk2.   

Abstract

Dabigatran etexilate is a substrate of the P-glycoprotein (adenosine triphosphate-binding cassette subfamily B member 1) transport system and is subject to interactions with medications that induce or inhibit this system. The clinical relevance of the interaction between dabigatran and phenytoin has not been well described. We report a case of left atrial thrombus in a patient receiving concomitant dabigatran etexilate and phenytoin, which is a P-glycoprotein inducer. This case illustrates the potential clinical significance of the interactions of medications that affect P-glycoprotein and dabigatran.
Copyright © 2016 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28063739     DOI: 10.1016/j.cjca.2016.10.022

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  6 in total

Review 1.  Drug-drug interactions in an era of multiple anticoagulants: a focus on clinically relevant drug interactions.

Authors:  Sara R Vazquez
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  Potential drug-drug interactions with direct oral anticoagulants in elderly hospitalized patients.

Authors:  Heather L Forbes; Thomas M Polasek
Journal:  Ther Adv Drug Saf       Date:  2017-07-11

3.  Left atrial appendage thrombus on full-dose dabigatran treatment: a case report.

Authors:  Paolo Candelaresi; Angela Iannuzzi; Giovanna Servillo; Rossella Gottilla
Journal:  Eur Heart J Case Rep       Date:  2020-04-24

4.  Prediction of potential drug interactions between repurposed COVID-19 and antitubercular drugs: an integrational approach of drug information software and computational techniques data.

Authors:  Levin Thomas; Sumit Raosaheb Birangal; Rajdeep Ray; Sonal Sekhar Miraj; Murali Munisamy; Muralidhar Varma; Chidananda Sanju S V; Mithu Banerjee; Gautham G Shenoy; Mahadev Rao
Journal:  Ther Adv Drug Saf       Date:  2021-08-26

Review 5.  Drug-drug interactions with direct oral anticoagulants associated with adverse events in the real world: A systematic review.

Authors:  Allen Li; Ming K Li; Mark Crowther; Sara R Vazquez
Journal:  Thromb Res       Date:  2020-08-11       Impact factor: 3.944

6.  Effect of Enzyme-Inducing Antiseizure Medications on the Risk of Sub-Therapeutic Concentrations of Direct Oral Anticoagulants: A Retrospective Cohort Study.

Authors:  Amichai Perlman; Rachel Goldstein; Lotan Choshen Cohen; Bruria Hirsh-Raccah; David Hakimian; Ilan Matok; Yosef Kalish; Daniel E Singer; Mordechai Muszkat
Journal:  CNS Drugs       Date:  2021-02-17       Impact factor: 5.749

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.